Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

prospectIve Non-interventional Study of Clinical Outcomes And Biomarkers in Patients With Stage 0-IV mElanoma in reaL clinicaL prActice

NCT05402059 is registered in ClinicalTrials.gov with MelanomaPRO, Russia as lead sponsor.

NCT NCT05402059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05402059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
prospectIve Non-interventional Study of Clinical Outcomes And Biomarkers in Patients With Stage 0-IV mElanoma in reaL clinicaL prActice
Lead sponsor
MelanomaPRO, Russia
Phase
Observational
Overall status
Unknown status
Start date
March 2, 2022
Completion date
April 30, 2025
Enrollment
1,570 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, melanoma (skin), melanoma in situ, melanoma stage iii, melanoma stage iv, melanoma, ocular, melanoma, stage ii, melanoma, uveal